雷竞技Newbee赞助商
Learn more about Spark’s progress, and explore our recent announcements and resources.
For additional media inquiries, please contact:communications@www.cqxywhcm.comor call 1-855-SPARKTX / +1 215-220-9300.
Press releases
Spark Therapeutics Announces Preliminary Data from Phase 1/2 Clinical Trial of SPK-8016 in Hemophilia A at EAHAD 2021 Virtual Congress
February 5, 2021
Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease
February 1, 2021
Spark Therapeutics Expands Visionary Leadership with Appointment of Michael Retterath as Chief Strategy Officer
November 16, 2020
In the news
The City of Biotech Love
Science
November 6, 2020
Shattering the Lab’s Glass Ceiling: Kathy High Joins Women Leaders in Science for Panel at BIO 2019
Philadelphia Magazine
June 6, 2019
Why the Country’s Top Biotech Companies Are Flocking to Philadelphia
Philadelphia Magazine
June 5, 2019
Philadelphia pitches its bonafides to biotech CEOs at confab, and some even seemed impressed
Medical Xpress
June 5, 2019
Top 10 Most Innovative Companies in Biotech
Fast Company
February 20, 2018
50 Companies to Watch
Bloomberg
October 31, 2017
Welcome to Cellacon Valley?
Philadelphia Magazine
June 17, 2017
From Hospital Research Project To Spark Therapeutics – Just One Of The Companies Creating Buzz At BIO CEO 2017
Life Science Leader
February 16, 2017
Spark lights up licensing deal valued at up to $460M
Philadelphia Business Journal
December 5, 2016
Spark launches genetic testing initiative for inherited eye disease
Philadelphia Business Journal
October 13, 2016
Despite the Hype Over Gene Therapy, Few Drugs Are Close to Approval
MIT Technology Review
September 29, 2016
Media Kit
Timeline on our product
Photo downloads
Click here
Chief Executive Officer
Contactcommunications@www.cqxywhcm.comfor access to downloadable corporate b-roll footage.
雷竞技官方
3737 Market Street
Philadelphia, PA 19104
Phone: 1-855-SPARKTX / +1 215-220-9300
N-UNBD-US-700020-6
